Add Yahoo as a preferred source to see more of our stories on Google. (The Hill) — Drugmaker Boehringer Ingelheim plans to cap the out-of-pocket costs for all its inhalers at $35 a month after coming ...

Add Yahoo as a preferred source to see more of our stories on Google. (The Hill) — Drugmaker AstraZeneca will cap out-of-pocket costs at $35 for all its inhaler products, the company announced Monday.

Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim. Subscribe to ...

Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Inhalers will soon get a whole lot cheaper for some Americans. Three of the world's ...

March 18 (Reuters) - Drugmaker AstraZeneca (AZN.L), opens new tab said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States from June, ...

Facing criticism over its pricing, Boehringer Ingelheim plans to cap out-of-pocket costs at $35 a month for its entire line of inhalers that are used to combat asthma and chronic obstructive pulmonary ...

Boehringer Ingelheim will cap out-of-pocket costs for its inhaler products at $35 per month starting in June. The drugmaker announced the move March 7, saying the program will apply to all seven of ...

(The Hill) — Drugmaker Boehringer Ingelheim plans to cap the out-of-pocket costs for all its inhalers at $35 a month after coming under fire from Democratic lawmakers over pricing. The company on ...

Drugmaker AstraZeneca will cap out-of-pocket costs at $35 for all its inhaler products, the company announced Monday. The cap is effective June 1 and will apply to the company’s entire range of ...